Q6CSZ7
Gene name |
DHH1 (KLLA0C16599g) |
Protein name |
ATP-dependent RNA helicase DHH1 |
Names |
|
Species |
Kluyveromyces lactis (strain ATCC 8585 / CBS 2359 / DSM 70799 / NBRC 1267 / NRRL Y-1140 / WM37) (Yeast) (Candida sphaerica) |
KEGG Pathway |
kla:KLLA0_C16599g |
EC number |
3.6.4.13: Acting on ATP; involved in cellular and subcellular movement |
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q6CSZ7
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q6CSZ7-F1 | Predicted | AlphaFoldDB |
No variants for Q6CSZ7
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| No variants for Q6CSZ7 | |||||
No associated diseases with Q6CSZ7
5 regional properties for Q6CSZ7
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| conserved_site | ATP-dependent RNA helicase DEAD-box, conserved site | 183 - 191 | IPR000629 |
| domain | Helicase, C-terminal | 247 - 407 | IPR001650 |
| domain | DEAD/DEAH box helicase domain | 61 - 225 | IPR011545 |
| domain | Helicase superfamily 1/2, ATP-binding domain | 55 - 251 | IPR014001 |
| domain | RNA helicase, DEAD-box type, Q motif | 36 - 64 | IPR014014 |
Functions
| Description | ||
|---|---|---|
| EC Number | 3.6.4.13 | Acting on ATP; involved in cellular and subcellular movement |
| Subcellular Localization |
|
|
| PANTHER Family | ||
| PANTHER Subfamily | ||
| PANTHER Protein Class | ||
| PANTHER Pathway Category | No pathway information available | |
3 GO annotations of cellular component
| Name | Definition |
|---|---|
| cytoplasmic side of membrane | The side of a membrane that faces the cytoplasm. |
| cytoplasmic stress granule | A dense aggregation in the cytosol composed of proteins and RNAs that appear when the cell is under stress. |
| P-body | A focus in the cytoplasm where mRNAs may become inactivated by decapping or some other mechanism. Protein and RNA localized to these foci are involved in mRNA degradation, nonsense-mediated mRNA decay (NMD), translational repression, and RNA-mediated gene silencing. |
5 GO annotations of molecular function
| Name | Definition |
|---|---|
| ATP binding | Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. |
| ATP hydrolysis activity | Catalysis of the reaction: ATP + H2O = ADP + H+ phosphate. ATP hydrolysis is used in some reactions as an energy source, for example to catalyze a reaction or drive transport against a concentration gradient. |
| chromatin binding | Binding to chromatin, the network of fibers of DNA, protein, and sometimes RNA, that make up the chromosomes of the eukaryotic nucleus during interphase. |
| mRNA binding | Binding to messenger RNA (mRNA), an intermediate molecule between DNA and protein. mRNA includes UTR and coding sequences, but does not contain introns. |
| RNA helicase activity | Unwinding of an RNA helix, driven by ATP hydrolysis. |
8 GO annotations of biological process
| Name | Definition |
|---|---|
| deadenylation-dependent decapping of nuclear-transcribed mRNA | Cleavage of the 5'-cap of a nuclear mRNA triggered by shortening of the poly(A) tail to below a minimum functional length. |
| mRNA processing | Any process involved in the conversion of a primary mRNA transcript into one or more mature mRNA(s) prior to translation into polypeptide. |
| mRNA transport | The directed movement of mRNA, messenger ribonucleic acid, into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. |
| negative regulation of translational elongation | Any process that stops, prevents, or reduces the frequency, rate or extent of translational elongation. |
| P-body assembly | The aggregation, arrangement and bonding together of proteins and RNA molecules to form a cytoplasmic mRNA processing body. |
| positive regulation of translation | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of proteins by the translation of mRNA or circRNA. |
| regulation of cytoplasmic mRNA processing body assembly | Any process that modulates the rate, frequency, or extent of the aggregation, arrangement and bonding together of proteins and RNA molecules to form a cytoplasmic mRNA processing body. |
| stress granule assembly | The aggregation, arrangement and bonding together of proteins and RNA molecules to form a stress granule. |
No homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| No homologous proteins | ||||
| 10 | 20 | 30 | 40 | 50 | 60 |
| MGSDTSESNN | DWKTQLNIPK | KDTRPQTDDV | LNTKGRSFED | FYLKRELLMG | IFEAGFEKPS |
| 70 | 80 | 90 | 100 | 110 | 120 |
| PIQEEAIPVA | IAGKDILARA | KNGTGKTAAF | VIPTLEKVKP | KLNKIQALIM | VPTRELALQT |
| 130 | 140 | 150 | 160 | 170 | 180 |
| SQVVRTLGKH | CGISCMVTTG | GTNLRDDIMR | LNEPVHILVG | TPGRVLDLAS | RRVTDLSECH |
| 190 | 200 | 210 | 220 | 230 | 240 |
| LFIMDEADKM | LSRDFKVLAE | QILGFLPERR | QLLLFSATFP | VTVKEFMVKH | LKNPHEINLM |
| 250 | 260 | 270 | 280 | 290 | 300 |
| DELTLKGISQ | FYAFVEEKQK | LHCLNTLFSK | LQINQAIIFC | NSTNRVELLA | KKITELGFSC |
| 310 | 320 | 330 | 340 | 350 | 360 |
| YYSHARMKQS | ERNKVFHEFR | QGKVRTLVCS | DLLTRGIDIQ | AVNVVINFDF | PKTAETYLHR |
| 370 | 380 | 390 | 400 | 410 | 420 |
| IGRSGRFGHL | GLAINLINWN | DRFNLYKIEQ | ELNTEIAPIP | SQIDKSLYVA | EDSSAVPIPF |
| 430 | 440 | 450 | 460 | 470 | 480 |
| PLESLPITAN | APQQPANAEP | LPPQQTQVQF | HAPPQQQQQQ | QQQQQQQQYQ | QFPNQQQQQY |
| 490 | 500 | 510 | |||
| GQPLMPQNYQ | QQAYPPQPFP | SKGFPQQQYT | QAPQ |